PIRS Old Ownership

The market capitalization of PIRS Old is $21.14 Million. Over half of PIRS Old's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

PIRS Stock Ownership Analysis

About 53.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PIRS Old recorded a loss per share of 12.11. The entity had not issued any dividends in recent years. The firm had 1:80 split on the 23rd of April 2024. Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts. Pieris Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 124 people. To find out more about PIRS Old contact Stephen JD at 857 246 8998 or learn more at https://www.pieris.com.

PIRS Old Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PIRS Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on PIRS Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases PIRS Old insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Adar1 Capital Management, Llc over three months ago
Discretionary transaction by Adar1 Capital Management, Llc of tradable shares of Pieris Pharmaceuticals subject to Rule 16b-3
 
Kiritsy Christopher P over three months ago
Acquisition by Kiritsy Christopher P of 500 shares of Pieris Pharmaceuticals at 16.43 subject to Rule 16b-3
 
Dellora Investments Lp over three months ago
Insider Trading
 
Dellora Investments Lp over three months ago
Insider Trading
 
Adar1 Capital Management, Llc over six months ago
Acquisition by Adar1 Capital Management, Llc of 757 shares of Pieris Pharmaceuticals at 15.8824 subject to Rule 16b-3
 
Adar1 Capital Management, Llc over six months ago
Acquisition by Adar1 Capital Management, Llc of 3000 shares of Pieris Pharmaceuticals at 14.8929 subject to Rule 16b-3
 
Barbier Ann over six months ago
Acquisition by Barbier Ann of 40000 shares of Pieris Pharmaceuticals at 0.26 subject to Rule 16b-3
 
Hitto Kaufmann over six months ago
Acquisition by Hitto Kaufmann of 215819 shares of Pieris Pharmaceuticals at 3.03 subject to Rule 16b-3
 
Peter Kiener over six months ago
Acquisition by Peter Kiener of 40000 shares of Pieris Pharmaceuticals subject to Rule 16b-3
 
Shane Olwill over six months ago
Acquisition by Shane Olwill of 215819 shares of Pieris Pharmaceuticals at 3.03 subject to Rule 16b-3
 
Michael Richman over a year ago
Acquisition by Michael Richman of 5165 shares of Pieris Pharmaceuticals subject to Rule 16b-3
 
Michael Richman over a year ago
Acquisition by Michael Richman of 40000 shares of Pieris Pharmaceuticals subject to Rule 16b-3

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in PIRS Stock

If you are still planning to invest in PIRS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PIRS Old's history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio